US Stock MarketDetailed Quotes

RARE Ultragenyx Pharmaceutical

Watchlist

40.390
+0.180+0.45%

Trading Jul 5 14:45 ET

3.66BMarket Cap-5080P/E (TTM)

Ultragenyx Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-21.59%-190.73M

-24.80%-474.81M

7.13%-83.9M

-23.63%-117.87M

-50.36%-116.16M

-33.48%-156.87M

-12.33%-380.47M

-66.24%-90.34M

-59.84%-95.35M

-18.21%-77.26M

Net income from continuing operations

-4.09%-170.68M

14.25%-606.64M

18.86%-123.19M

34.87%-159.65M

-1.05%-159.83M

-7.65%-163.97M

-55.81%-707.42M

-23.99%-151.83M

-235.77%-245.11M

-29.19%-158.16M

Depreciation and amortization

68.93%8.85M

42.73%26.01M

65.79%8.22M

53.20%7.19M

19.64%5.36M

28.08%5.24M

37.62%18.22M

40.27%4.96M

45.91%4.69M

43.58%4.48M

Other non cash items

-120.96%-2.29M

-101.10%-1.06M

-214.99%-10.14M

-102.17%-1.83M

-102.76%-27K

514.32%10.94M

721.17%96.13M

877.18%8.82M

2,037.11%84.54M

-75.59%980K

Change In working capital

-46.02%-56.02M

-125.07%-15.1M

-39.11%13.3M

-87.37%2.8M

-74.35%7.16M

-228.21%-38.36M

195.25%60.24M

5.60%21.85M

614.57%22.17M

385.64%27.91M

-Change in receivables

-893.14%-24.91M

-88.75%-22.78M

111.13%1.01M

-204.64%-6.2M

-68.75%-15.08M

-7,700.00%-2.51M

-122.16%-12.07M

-196.25%-9.1M

955.56%5.93M

-2,857.72%-8.94M

-Change in inventory

-1,516.00%-2.12M

28.56%-6.93M

53.48%-1.96M

-338.31%-3.47M

48.70%-1.66M

110.17%150K

-211.23%-9.7M

-324.75%-4.21M

-1,782.98%-791K

-21.98%-3.23M

-Change in prepaid assets

1,362.62%6.55M

303.50%15.33M

-138.86%-1.26M

-32.12%4.99M

176.09%12.11M

-105.69%-519K

112.87%3.8M

114.38%3.24M

263.37%7.35M

-1,062.45%-15.92M

-Change in payables and accrued expense

-0.15%-35.54M

-97.28%2.38M

-51.10%17.13M

-32.94%7.48M

-76.91%13.26M

-119.54%-35.49M

170.61%87.44M

15.24%35.03M

-17.03%11.16M

375.52%57.42M

-Change in other working capital

----

66.46%-3.1M

48.08%-1.62M

--0

----

83.94%-9.24M

-118.47%-3.12M

87.38%-1.48M

93.25%-1.43M

Cash from discontinued investing activities

Operating cash flow

-21.59%-190.73M

-24.80%-474.81M

7.13%-83.9M

-23.63%-117.87M

-50.36%-116.16M

-33.48%-156.87M

-12.33%-380.47M

-66.24%-90.34M

-59.84%-95.35M

-18.21%-77.26M

Investing cash flow

Cash flow from continuing investing activities

-15.16%94.44M

157.60%168M

37.64%-107.02M

139.72%64.3M

25.58%99.42M

397.91%111.3M

-49.28%-291.65M

-348.49%-171.6M

-297.11%-161.86M

291.94%79.17M

Net PPE purchase and sale

87.17%-3.21M

61.88%-44.27M

94.07%-1.6M

85.81%-3.7M

54.93%-13.94M

22.22%-25.03M

-58.87%-116.12M

-68.06%-26.97M

-26.68%-26.05M

-54.07%-30.92M

Net intangibles purchase and sale

---10M

91.67%-2.5M

--0

---2.5M

--0

---30M

--0

Net business purchase and sale

----

--0

----

---75.03M

--366K

----

Net investment purchase and sale

-21.80%109.71M

415.55%219.82M

27.18%-105.15M

213.57%68.42M

5.42%116.25M

467.93%140.29M

42.59%-69.66M

-268.76%-144.39M

-205.63%-60.25M

620.77%110.27M

Net other investing changes

47.73%-2.07M

-498.10%-5.05M

55.13%-271K

-141.81%-428K

-117.49%-398K

-3,392.50%-3.95M

10.40%-844K

-32.75%-604K

---177K

---183K

Cash from discontinued investing activities

Investing cash flow

-15.16%94.44M

157.60%168M

37.64%-107.02M

139.72%64.3M

25.58%99.42M

397.91%111.3M

-49.28%-291.65M

-348.49%-171.6M

-297.11%-161.86M

291.94%79.17M

Financing cash flow

Cash flow from continuing financing activities

91.97%-58K

-22.56%388.14M

17,466.95%330.61M

-94.87%25.23M

465.70%33.02M

-144.79%-722K

322.77%501.21M

-97.80%1.88M

6,414.93%491.88M

-53.78%5.84M

Net common stock issuance

----

--379.76M

--326.46M

--24.79M

----

--0

----

Proceeds from stock option exercised by employees

92.27%-58K

-22.18%8.42M

107.60%4.15M

-58.85%442K

-23.63%4.57M

-142.74%-750K

-73.04%10.81M

-71.10%2M

-86.00%1.07M

-53.05%5.98M

Net other financing activities

----

-100.01%-28K

--0

61.64%-56K

119.58%28K

99,773.78%490.4M

16.20%-119K

395,908.87%490.8M

-28.07%-146K

Cash from discontinued financing activities

Financing cash flow

91.97%-58K

-22.56%388.14M

17,466.95%330.61M

-94.87%25.23M

465.70%33.02M

-144.79%-722K

322.77%501.21M

-97.80%1.88M

6,414.93%491.88M

-53.78%5.84M

Net cash flow

Beginning cash position

59.45%219.4M

-55.55%137.6M

-80.17%78.61M

-33.83%107.67M

-41.41%91.53M

-55.55%137.6M

-57.37%309.59M

89.13%396.31M

-46.28%162.72M

-60.59%156.21M

Current changes in cash

-108.17%-96.35M

147.59%81.34M

153.71%139.69M

-112.08%-28.35M

110.08%16.28M

69.80%-46.29M

58.87%-170.91M

-358.92%-260.06M

352.72%234.67M

108.24%7.75M

Effect of exchange rate changes

-421.80%-679K

142.98%462K

-18.42%1.1M

33.77%-716K

89.01%-136K

295.37%211K

9.97%-1.08M

444.90%1.35M

-125.68%-1.08M

-376.34%-1.24M

End cash Position

33.70%122.37M

59.45%219.4M

-80.17%78.61M

-33.83%107.67M

-41.41%91.53M

-55.55%137.6M

89.13%396.31M

-46.28%162.72M

Free cash flow

-12.11%-203.94M

0.95%-521.57M

27.11%-85.5M

-0.15%-121.57M

-22.57%-132.6M

-1.22%-181.9M

-27.88%-526.59M

-66.66%-117.31M

-51.34%-121.39M

-26.63%-108.18M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-21.59%-190.73M	-24.80%-474.81M	7.13%-83.9M	-23.63%-117.87M	-50.36%-116.16M	-33.48%-156.87M	-12.33%-380.47M	-66.24%-90.34M	-59.84%-95.35M	-18.21%-77.26M
Net income from continuing operations	-4.09%-170.68M	14.25%-606.64M	18.86%-123.19M	34.87%-159.65M	-1.05%-159.83M	-7.65%-163.97M	-55.81%-707.42M	-23.99%-151.83M	-235.77%-245.11M	-29.19%-158.16M
Depreciation and amortization	68.93%8.85M	42.73%26.01M	65.79%8.22M	53.20%7.19M	19.64%5.36M	28.08%5.24M	37.62%18.22M	40.27%4.96M	45.91%4.69M	43.58%4.48M
Other non cash items	-120.96%-2.29M	-101.10%-1.06M	-214.99%-10.14M	-102.17%-1.83M	-102.76%-27K	514.32%10.94M	721.17%96.13M	877.18%8.82M	2,037.11%84.54M	-75.59%980K
Change In working capital	-46.02%-56.02M	-125.07%-15.1M	-39.11%13.3M	-87.37%2.8M	-74.35%7.16M	-228.21%-38.36M	195.25%60.24M	5.60%21.85M	614.57%22.17M	385.64%27.91M
-Change in receivables	-893.14%-24.91M	-88.75%-22.78M	111.13%1.01M	-204.64%-6.2M	-68.75%-15.08M	-7,700.00%-2.51M	-122.16%-12.07M	-196.25%-9.1M	955.56%5.93M	-2,857.72%-8.94M
-Change in inventory	-1,516.00%-2.12M	28.56%-6.93M	53.48%-1.96M	-338.31%-3.47M	48.70%-1.66M	110.17%150K	-211.23%-9.7M	-324.75%-4.21M	-1,782.98%-791K	-21.98%-3.23M
-Change in prepaid assets	1,362.62%6.55M	303.50%15.33M	-138.86%-1.26M	-32.12%4.99M	176.09%12.11M	-105.69%-519K	112.87%3.8M	114.38%3.24M	263.37%7.35M	-1,062.45%-15.92M
-Change in payables and accrued expense	-0.15%-35.54M	-97.28%2.38M	-51.10%17.13M	-32.94%7.48M	-76.91%13.26M	-119.54%-35.49M	170.61%87.44M	15.24%35.03M	-17.03%11.16M	375.52%57.42M
-Change in other working capital	----	66.46%-3.1M	48.08%-1.62M	--0	----	----	83.94%-9.24M	-118.47%-3.12M	87.38%-1.48M	93.25%-1.43M
Cash from discontinued investing activities
Operating cash flow	-21.59%-190.73M	-24.80%-474.81M	7.13%-83.9M	-23.63%-117.87M	-50.36%-116.16M	-33.48%-156.87M	-12.33%-380.47M	-66.24%-90.34M	-59.84%-95.35M	-18.21%-77.26M
Investing cash flow
Cash flow from continuing investing activities	-15.16%94.44M	157.60%168M	37.64%-107.02M	139.72%64.3M	25.58%99.42M	397.91%111.3M	-49.28%-291.65M	-348.49%-171.6M	-297.11%-161.86M	291.94%79.17M
Net PPE purchase and sale	87.17%-3.21M	61.88%-44.27M	94.07%-1.6M	85.81%-3.7M	54.93%-13.94M	22.22%-25.03M	-58.87%-116.12M	-68.06%-26.97M	-26.68%-26.05M	-54.07%-30.92M
Net intangibles purchase and sale	---10M	91.67%-2.5M	--0	--0	---2.5M	--0	---30M	--0	--0	--0
Net business purchase and sale	----	--0	--0	----	----	----	---75.03M	--366K	----	----
Net investment purchase and sale	-21.80%109.71M	415.55%219.82M	27.18%-105.15M	213.57%68.42M	5.42%116.25M	467.93%140.29M	42.59%-69.66M	-268.76%-144.39M	-205.63%-60.25M	620.77%110.27M
Net other investing changes	47.73%-2.07M	-498.10%-5.05M	55.13%-271K	-141.81%-428K	-117.49%-398K	-3,392.50%-3.95M	10.40%-844K	-32.75%-604K	---177K	---183K
Cash from discontinued investing activities
Investing cash flow	-15.16%94.44M	157.60%168M	37.64%-107.02M	139.72%64.3M	25.58%99.42M	397.91%111.3M	-49.28%-291.65M	-348.49%-171.6M	-297.11%-161.86M	291.94%79.17M
Financing cash flow
Cash flow from continuing financing activities	91.97%-58K	-22.56%388.14M	17,466.95%330.61M	-94.87%25.23M	465.70%33.02M	-144.79%-722K	322.77%501.21M	-97.80%1.88M	6,414.93%491.88M	-53.78%5.84M
Net common stock issuance	----	--379.76M	--326.46M	--24.79M	----	----	--0	--0	--0	----
Proceeds from stock option exercised by employees	92.27%-58K	-22.18%8.42M	107.60%4.15M	-58.85%442K	-23.63%4.57M	-142.74%-750K	-73.04%10.81M	-71.10%2M	-86.00%1.07M	-53.05%5.98M
Net other financing activities	----	-100.01%-28K	--0	--0	61.64%-56K	119.58%28K	99,773.78%490.4M	16.20%-119K	395,908.87%490.8M	-28.07%-146K
Cash from discontinued financing activities
Financing cash flow	91.97%-58K	-22.56%388.14M	17,466.95%330.61M	-94.87%25.23M	465.70%33.02M	-144.79%-722K	322.77%501.21M	-97.80%1.88M	6,414.93%491.88M	-53.78%5.84M
Net cash flow
Beginning cash position	59.45%219.4M	-55.55%137.6M	-80.17%78.61M	-33.83%107.67M	-41.41%91.53M	-55.55%137.6M	-57.37%309.59M	89.13%396.31M	-46.28%162.72M	-60.59%156.21M
Current changes in cash	-108.17%-96.35M	147.59%81.34M	153.71%139.69M	-112.08%-28.35M	110.08%16.28M	69.80%-46.29M	58.87%-170.91M	-358.92%-260.06M	352.72%234.67M	108.24%7.75M
Effect of exchange rate changes	-421.80%-679K	142.98%462K	-18.42%1.1M	33.77%-716K	89.01%-136K	295.37%211K	9.97%-1.08M	444.90%1.35M	-125.68%-1.08M	-376.34%-1.24M
End cash Position	33.70%122.37M	59.45%219.4M	59.45%219.4M	-80.17%78.61M	-33.83%107.67M	-41.41%91.53M	-55.55%137.6M	-55.55%137.6M	89.13%396.31M	-46.28%162.72M
Free cash flow	-12.11%-203.94M	0.95%-521.57M	27.11%-85.5M	-0.15%-121.57M	-22.57%-132.6M	-1.22%-181.9M	-27.88%-526.59M	-66.66%-117.31M	-51.34%-121.39M	-26.63%-108.18M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall